The E-Morph Screening Assay: Phenotypic Screening for Estrogenic or Anti-estrogenic Compound Activities

Area of Science:

• Endocrinology
• Cell Biology
• Toxicology

Background:

• Compounds interfering with the estrogen hormone system pose risks to human health and the environment.
• Estrogenic and anti-estrogenic compounds require efficient detection methods.

Purpose of the Study:

• To describe the E-Morph Screening Assay for identifying and characterizing compounds with estrogenic or anti-estrogenic activities.
• To provide a high-throughput screening method for evaluating estrogen signaling pathway modulators.

Main Methods:

• Utilized MCF-7 breast cancer cells, which possess a complete estrogen signaling pathway.
• Employed a targeted, imaging-based, high-throughput phenotypic screening assay in 96- or 384-well plate formats.
• Measured E-Cadherin-GFP signal intensity at adherens junctions as a quantitative readout for phenotypic changes.

Main Results:

• The E-Morph Screening Assay allows for the efficient identification of compounds with estrogenic or anti-estrogenic activities.
• The assay provides a quantitative readout for estrogen-dependent changes in cell-cell contact morphology.
• Demonstrated the capability to characterize the effects of endocrine-disrupting compounds.

Conclusions:

• The E-Morph Screening Assay is an effective tool for screening compounds that modulate the estrogen signaling pathway.
• This assay facilitates the assessment of potential endocrine disruptors in a high-throughput manner.
• The method offers a valuable approach for evaluating environmental and health risks associated with estrogenic compounds.